A U.S. federal court has approved a settlement between Novo Nordisk (NVO) and Minnesota ending a longstanding litigation that ...
As Novo Nordisk A/S shares head for their worst month in more than two decades, the days when the Danish drugmaker was valued at more than $600 billion are becoming a distant memory.
Bullish option flow detected in Novo Nordisk (NVO) with 6,619 calls trading, 1.5x expected, and implied vol increasing over 2 points to 42.66%. Jun-25 65 puts and May-25 90 calls are the most ...
Novo Nordisk NVO shares have lost 15.2% so far this month compared with the industry’s decline of 4.6%. The company has also underperformed in the sector and the S&P 500 during the same time ...
Morgan Stanley analyst Thibault Boutherin lowered the firm’s price target on Novo Nordisk (NVO) to DKK 600 from DKK 700 and keeps an Equal Weight rating on the shares. Published first on TheFly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results